Navigation Links
Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target

ropin alfa, and is expected to complete recruitment on target by mid-August 2007.

About corifollitropin alfa
• Corifollitropin alfa is a new biological entity (NBE) and is being developed for controlled ovarian stimulation to induce the development of multiple follicles in patients participating in an assisted reproductive technology program.
• Corifollitropin alfa is the first compound in a new class of long-acting fertility hormones called ‘Sustained Follicle Stimulants’ (SFS). The primary advantage of an SFS over current gonadotropins is the longer duration of action which allows a treatment regimen replacing 7 daily injections of current gonadotropins with one injection of corifollitropin alfa.
• The LIFE program is Organon’s clinical development program for corifollitropin alfa for the therapeutic indication of controlled ovarian stimulation. The most important trials in this program are studies with the names ENGAGE (phase III efficacy and safety study with corifollitropin alfa 150 mcg), ENSURE (phase III efficacy and safety study in women =60 kg with corifollitropin alfa 100 mcg) and TRUST (phase III safety study on repeated treatment).


For media inquiries
Elina Daamen

N.V. Organon (Media Relations)
Visiting address: Molenstraat 110
5342 CC Oss
The Netherlands
Mailing address:

Elina Daamen, media relations

NV Organon






Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:4/1/2015)... Pa. , April 1, 2015  Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... pricing of an offering of $60.0 million aggregate ... 2020 (the "notes") in a private placement to ... the Securities Act of 1933, as amended (the ...
(Date:4/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/n9mxqs/an_introduction ) has ... the Medical Device Directives" conference to their offering. ... the European medical device legislation. It will explain the ... Notified Bodies, how to choose one and outline what ... documentation necessary to apply for the CE mark. ...
(Date:4/1/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... medical paper has been published describing the positive ... with severe dry eye.  The results met key ... stated that statistically significant differences in both signs ... at various time points throughout the study.  Of ...
Breaking Medicine Technology:Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3
... May 5, 2011 Ridge Diagnostics, Inc., a ... at the 6th Annual Neurotech Investing and Partnering Conference to ... Hotel on May 9th and 10th.   Ms. ... panel entitled "Next Generation Psychiatry" lead by Dr. Manuel Lopez-Figueroa, ...
... INDIANAPOLIS, May 5, 2011 Eli Lilly and Company ... an Indianapolis-based nonprofit that supports bold, new education reform, ... What Works campaign. Grow What Works seeks to raise ... working in Indianapolis, enabling them to serve more students ...
Cached Medicine Technology:Ridge Diagnostics, Inc. CEO to Speak at Neurotech Investing and Partnering Conference 2Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 2Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 3Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 4
(Date:4/1/2015)... The panel session will look at the need ... a program that can grow in a privacy-friendly manner, ... the line. This topic has taken on even greater ... port dongles aren’t as secure as the automobile industry ... that Progressive’s Snapshot dongles contained very significant security flaws, ...
(Date:4/1/2015)... After a particularly harsh winter, many roads are now littered ... damage, so Amica Insurance has tips to help ... from AAA: , , Inspect tires: Tires ... manufacturer’s recommended levels. , Inspect suspension: ... wear can be signs of bad shocks or struts. Have ...
(Date:4/1/2015)... FL (PRWEB) April 01, 2015 Baby ... to providing the latest information on the top products ... to set the Guinness World Records title for "Mommy ... part of the 1st annual Baby Bellies & Beyond ... 10am, and the Guinness World Record will commence at ...
(Date:4/1/2015)... New York, New York (PRWEB) April 01, 2015 ... litigation housing hundreds of Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ... According to the calendar for the Philadelphia Court of ... in Court Room 206, City Hall. Court records indicate ... liability claims filed on behalf of Risperdal users who ...
(Date:4/1/2015)... BioPlus Specialty Pharmacy (BioPlus), one ... a new app to keep health care providers informed ... C virus (HCV) infection. This ‘HCV Treatment Path’ app ... American Association for the Study of Liver Diseases (AASLD) ... oral medications to treat HCV have been approved by ...
Breaking Medicine News(10 mins):Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 3Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 3Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2
... light on empathic response , WEDNESDAY, July 1 (HealthDay News) ... to a new study. , Neuroimaging of the anterior ... linked to emotional response -- shows more activity when a ... social group, such as the same race. The findings, in ...
... Millennium Pharmacy Systems, a leading provider of pharmacy services to ... Retirement Home (AFRH) selected Millennium as its pharmacy service provider. ... AFRH cited Millennium,s ability to automate prescription ordering and fulfillment ... , , "The health care industry in the ...
... TrinityCare Senior Living, Inc. (OTC Bulletin Board: TCSR), which ... announced that its company information will be made available ... an information distribution service that enables subscribing publicly traded ... of Standard & Poor,s Advisor Insight. , ...
... The Pennsylvania Breast Cancer Coalition (PBCC) is looking ... their traveling photo exhibit, "67 Women, 67 Counties: Facing ... face of breast cancer in their community and represent ... contact Jennifer Fetich at 717/ 721-2580 x101 or by ...
... ... and engineers, metallurgists, product designers, researchers, and clinicians is coming to Minneapolis, Aug. 10-12. ... (Vocus) July ... engineers, metallurgists, product designers, researchers, and clinicians is coming to Minneapolis, Aug. 10-12., , ...
... HealthFitness (NYSE: FIT ) today announced ... small- to mid-size companies in west Texas innovative solutions ... fully insured lives. , , (Logo: ... Program, we have made employee wellness programs affordable for ...
Cached Medicine News:Health News:Shared Race, Social Group Seem to Help People Relate 2Health News:Armed Forces Retirement Home Selects Millennium's Pharmacy Services 2Health News:TrinityCare Senior Living, Inc. Information to be Available Through Standard & Poor's Market Access Program 2Health News:The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania 2Health News:Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together 2Health News:Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together 3Health News:Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together 4Health News:New Partnership Between FirstCare and HealthFitness Provides Cost-Effective Preventive Health Solutions for Small- to Mid-Size Companies 2Health News:New Partnership Between FirstCare and HealthFitness Provides Cost-Effective Preventive Health Solutions for Small- to Mid-Size Companies 3Health News:New Partnership Between FirstCare and HealthFitness Provides Cost-Effective Preventive Health Solutions for Small- to Mid-Size Companies 4
... The PowerLab/8SP is a high-performance data ... of life science research applications that require ... is capable of recording at speeds of ... continuously to disk, and is compatible with ...
Worth 4-Dot Flashlight/Plastic for testing and training of visual functions and testing for fusion, suppression and/or diplopia. Red/green goggle included. Requires 2 C batteries (not included)....
This card is ideal for testing illiterate patients. It has HOTV letters on one side and Allen figures on the other. Card should be held at 16" 5" X 8"....
Binkhorst Hook (Left) 2.5 mm wide J Shape (0.64 mm x 25 mm)....
Medicine Products: